CRMD - Company ID 0001410098
The table below shows CorMedix Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $42.38M | $19.74M | -$17.31M | -$10.39M | -$6.74M | -$6.69M |
| Capital expenditure | $729.00K | $10.00K | $61.31K | $14.77K | $4.32K | $13.08K |
| Investing cash flow | $2.96M | -$195.00K | $8.94M | -$14.69M | -$4.19M | -$526.02K |
| Dividends paid | - | - | - | - |
CorMedix Inc. reported operating cash flow of $175.05M for fiscal year 2025. That is up 445.8% from -$50.62M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$22.27M (FY 2016) to $175.05M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | $11.09M | $0.00 | - | - | - | - |
| Financing cash flow | -$12.10M | $6.09M | -$97.12K | $7.20M | $3.00M | $41.58M |